New evidence generation program for medical aids care at home in the Netherlands

14

Aug 2020

In July 2020, new subsidy options for medical aids care at home became available within the Dutch program Good use of care at home (GGH). By funding research, the GGH program stimulates knowledge development about the quality, safety, effectiveness, and efficiency of innovative medical aids care at home. The deadline for submitting applications is 6 October 2020.

The GGH program focuses on research on the effectiveness and costs of medical aids care at home. This concerns primary medical care that belongs to or may become part of the Health Insurance Act (Zvw) in the future. Because of the social developments surrounding 'Right care in the right place,' the cross-domain problems, and the substitution of care, there is limited scope for research into medical care at home through the Social Support Act (Wmo) and the Long-Term Care Act (WIz). That is why the ideas for the project might be discussed via email to AIDS@zonmw.nl.

The total budget for this subsidy round is €2.2 million. The target amount per project is €600,000 if properly substantiated in the budget. The maximum duration of a project is six years.

The full details in Dutch can be found here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

25

Mar 2022

On March 4, 2022, the Dutch Healthcare Institute (Zorginstituut Nederland, ZIN) announced three projects which received a subsidy under the "Subsidy scheme for promising care" in 2022 for research of a new minimally invasive endoscopy-guided surgery in patients with spontaneous cerebral hemorrhage, oral immunotherapy in children to cure a food allergy and cutting the diaphragm band in chronic abdominal complaints.

Read more

18

Feb 2022

Dutch Organization for Health Research and Development, ZonMw awarded eight projects under the "Healthcare Evaluation and Appropriate Use" program, including two projects for geriatric care, two projects for cancer, per one project for cardiovascular, neurovascular, and dermatology care.

Read more

08

Feb 2022

Dutch Healthcare Institute (ZIN) has issued a Pilot Horizon Scan of 39 new diabetes-related MedTech products that are expected on the Dutch market in 2022 or 2023. Patients with diabetes could benefit significantly from the use of these devices. However, available data on their effectiveness and efficiency is limited.

Read more

19

Jan 2022

The French National Authority for Health (HAS) released new recommendations about add-on reimbursement of medical devices and medical aids from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in December 2021. More than 15 recommendations were published in relation to the registration, modification of registration conditions, renewal of registration of devices in the List of reimbursable products and services (LPPR). Opinions concern cardiovascular, orthopedic, ENT devices, as well as medical aids. Except for this, CNEDiMTS published an opinion about transitional coverage (a newly established pathway for reimbursement) for a cardiovascular device.

Read more

17

Jan 2022

Dutch Healthcare Authority (NZa) has issued a draft release of the DRG package for 2023, including a new procedure code for intermittent pneumatic compression therapy, a new diagnosis code for guidance in early pregnancy after a fertility program, and several new DRGs for pediatric palliative care, lymphovenous anastomosis surgery and light therapy in inflammatory dermatoses.

Read more